Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transepidermal water loss reduction" is not a molecular target such as a receptor, enzyme, or transporter. Instead, it refers to the process of decreasing the evaporation of water through the outermost layer of the skin—the stratum corneum. This physiological process is crucial for maintaining healthy skin barrier function and preventing dehydration, irritation, and other signs of compromised skin health. Excessive transepidermal water loss can result in weakened barrier function and increased vulnerability to environmental stressors. Various skincare products aim to reduce TEWL by reinforcing the skin’s natural moisture retention mechanisms using ingredients like hyaluronic acid complexes and occlusive agents[1].
Moisturization Barrier reinforcement Reduction of water evaporation from the stratum corneum[1]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transepidermal water loss reduction (TEWL reduction).